A detailed history of Headlands Technologies LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 1,404 shares of CTLT stock, worth $85,615. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,404
Previous 8,836 84.11%
Holding current value
$85,615
Previous $496,000 82.86%
% of portfolio
0.01%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.16 - $60.96 $417,381 - $453,054
-7,432 Reduced 84.11%
1,404 $85,000
Q2 2024

Aug 07, 2024

BUY
$53.58 - $57.02 $320,461 - $341,036
5,981 Added 209.49%
8,836 $496,000
Q1 2024

May 07, 2024

BUY
$42.56 - $59.82 $61,158 - $85,961
1,437 Added 101.34%
2,855 $161,000
Q4 2023

Feb 02, 2024

BUY
$32.18 - $46.57 $45,631 - $66,036
1,418 New
1,418 $63,000
Q1 2023

May 01, 2023

BUY
$45.44 - $74.26 $7,270 - $11,881
160 New
160 $10,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.